Database of Pharmaceutical Cases

Date of Settlement Settling Entities Lead State(s) Participating States Related Single State Settlements Description of Allegations Key Settlement Terms
wdt_ID Date of Settlement Settling Entities Lead State(s) Participating States Related Single State Settlements Description of Allegations Key Settlement Terms
1 02/07/1990 Allied International - CA, CO, FL, IL, IA, MO, TX, WV, VT AGs alleged that contrary to the company's advertising claims, the company's pills did not cause perceptible weight or fat loss. A court order halted the advertising of a mail-order diet pill when a government agency charged that ads for the pills contained false and unsubstantiated claims.
2 08/30/1990 Miles, Inc. - NY, CA, TX The AGs had been investigating claims by One-A-Day that the vitamins were necessary or effective in preventing or reversing the health effects of air pollution, ordinary stress or routine exercise. Miles agreed to stop making health claims in advertising.
3 02/20/1991 Pfizer TX TX, CA, FL, IL, IA, MA, MN, MO, NY, WI The case involves claims by Pfizer Inc. that Plax mouthwash helps remove plaque from teeth. Pfizer and Ally & Gargano agreed to no longer represent that the product can be used in the diagnosis, cure, treatment or prevention of tooth or gum disease. The companies also agreed to no longer claim that rinsing with Plax before brushing can remove 30
4 10/10/1991 Bristol-Myers Squibb - NY, CA, FL, MA, MN, MO, TN, TX, WA, WI The states contended Bristol-Myers improperly labeled some of its hair sprays, household cleaners and suntan lotions as "ozone safe" and "environmentally safe." The products contained propellants and other ingredients that contributed to ground-level ozon Agreed to refrain from asserting its ingredients are environmentally safe if the ingredients contribute to ground level pollution.
5 01/02/1992 Nu Skin International Inc. OH, PA, MI, IL, FL PA, OH, MI, IL, FL Involved allegations that some Nu Skin distributors were promising fantastic financial profits for prospective recruits and using possibly illegal pyramid scheme tactics. Also alleged that consumers were losing thousands of dollars because they were unabl Among the agreements' terms, Nu Skin will regulate its distributors' sales, ensuring that 80% of a distributor's monthly sales are made to at least five customers not participating in the program and the company will implement a 90% refund policy for dist
6 09/02/1992 Sandoz Pharmaceuticals CA, CT, MA, MN, NJ, NY, WA, VA AL, AZ, CA, CO, CT, DE, DC, FL, ID, IL, IA, KS, ME, MD, MA, MN, NH, NJ, NY, NC, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WV, WI The lawsuit sought to end the expensive practice of "bundling," the required combining of drug purchase with blood drawing, testing and monitoring services from a specific company. Under the bundled arrangement, Clozaril cost $8,944 per patient per year, The settlement will bar Sandoz from tying the sale of Clorazil to the monitoring service, allow other health care providers to perform blood monitoring services and require Sandoz to share information about Clorazil treatment to competitors and research
7 11/13/1992 Pacesetter Seminars of America OR OR Involved allegedly false claims regarding the product's fuel savings and emissions reduction in motor vehicles. Tests of cars at the Automotive Testing Laboratories, Inc., in Ohio disclosed that there was no improvement in emissions reduction or gas savin Pacesetter agreed to discontinue operations in the thirteen states, and pay $50,000 for the tests indicating that the product did not work as advertised.
8 12/18/1992 Better Health, Inc. MN, WI MN, WI AGs alleged that the company's product, which was sold over- the-counter at pharmacies, was not proven to be safe and effective in producing weight loss. According to the Attorneys General, the company falsely advertised in newspapers, claiming that the p The settlement required the recall of the weight-loss pill.
9 03/15/1993 CIBA-Geigy Corp. MN MN, CA, AZ, IL, IA, MA, MO, NM, NY, NC, TX The Attorneys General alleged that in its advertisements for the prescription drug Habitrol, CIBA-Geigy violated state consumer protection laws prohibiting false advertising and deceptive trade practices by failing to disclose important information about Under the settlement, CIBA-Geigy Corporation may not claim in its consumer advertisements that Habitrol alone will help people quit smoking. The settlement requires CIBA-Geigy to disclose significant facts about its nicotine patch in direct-to- consumer a
10 04/29/1993 Nature's Way Products - AZ, CA, IA, MN, MO, NM, NY, NC, PA, TX, WI The litigation arose because the Food and Drug Administration has banned guar gum in over-the-counter weight control products because its effectiveness for weight control has not been demonstrated and because it poses a significant health risk to consumer The agreement bars them from selling, distributing, or advertising products containing guar gum as a dietary aid.